INNER-CITY ANTI-IGE THERAPY FOR ASTHMA

内城区哮喘抗 ​​IGE 治疗

• 批准号: 7606294
• 负责人: GEORGE T O'CONNOR
• 金额: $ 0.73万
• 依托单位: BOSTON UNIVERSITY MEDICAL CAMPUS
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-01-03 至 2007-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7606294
• 关键词: 20 year old; Adolescent; Age; Asthma; Caring; Child; Computer Retrieval of Information on Scientific Projects Database; Double-Blind Method; Education; Extrinsic asthma; Funding; Grant; Institution; Placebo Control; Randomized; Research; Research Personnel; Resources; Safety; Source; Specialist; United States National Institutes of Health; Xolair; design; inner city

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The Inner-City Anti-IGE Therapy for Asthma study is a randomized, double-blind, placebo-controlled, parallel group efficacy and safety trial designed to compare 250 inner-city children and adolescents age 6-20 years old with moderate-to-severe allergic asthma receiving standardized care, including basic asthma education, with 250 similar children and adolescents receiving comparable standardized specialist care and treatment with Xolair.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 Inner-City Anti-IGE Therapy for Asthma研究是一项随机、双盲、安慰剂对照、平行组疗效和安全性试验，旨在比较250名接受标准化护理（包括基础哮喘教育）的6-20岁市中心儿童和青少年，以及250名接受类似标准化专科护理和Xolair治疗的儿童和青少年。